Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
Breast cancer (BC) is the most diagnosed cancer in women and the second most common cancer globally. Significant advances in BC research have led to improved early detection and effective therapies. One of the key challenges in BC is the presence of BC stem cells (BCSCs). This small subpopulation wi...
Saved in:
Published in | International journal of molecular sciences Vol. 24; no. 21; p. 16010 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
01.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Breast cancer (BC) is the most diagnosed cancer in women and the second most common cancer globally. Significant advances in BC research have led to improved early detection and effective therapies. One of the key challenges in BC is the presence of BC stem cells (BCSCs). This small subpopulation within the tumor possesses unique characteristics, including tumor-initiating capabilities, contributes to treatment resistance, and plays a role in cancer recurrence and metastasis. In recent years, microRNAs (miRNAs) have emerged as potential regulators of BCSCs, which can modulate gene expression and influence cellular processes like BCSCs’ self-renewal, differentiation, and tumor-promoting pathways. Understanding the miRNA signatures of BCSCs holds great promise for improving BC diagnosis and prognosis. By targeting BCSCs and their associated miRNAs, researchers aim to develop more effective and personalized treatment strategies that may offer better outcomes for BC patients, minimizing tumor recurrence and metastasis. In conclusion, the investigation of miRNAs as regulators of BCSCs opens new directions for advancing BC research through the use of bioinformatics and the development of innovative therapeutic approaches. This review summarizes the most recent and innovative studies and clinical trials on the role of BCSCs miRNAs as potential tools for early diagnosis, prognosis, and resistance. |
---|---|
AbstractList | Breast cancer (BC) is the most diagnosed cancer in women and the second most common cancer globally. Significant advances in BC research have led to improved early detection and effective therapies. One of the key challenges in BC is the presence of BC stem cells (BCSCs). This small subpopulation within the tumor possesses unique characteristics, including tumor-initiating capabilities, contributes to treatment resistance, and plays a role in cancer recurrence and metastasis. In recent years, microRNAs (miRNAs) have emerged as potential regulators of BCSCs, which can modulate gene expression and influence cellular processes like BCSCs’ self-renewal, differentiation, and tumor-promoting pathways. Understanding the miRNA signatures of BCSCs holds great promise for improving BC diagnosis and prognosis. By targeting BCSCs and their associated miRNAs, researchers aim to develop more effective and personalized treatment strategies that may offer better outcomes for BC patients, minimizing tumor recurrence and metastasis. In conclusion, the investigation of miRNAs as regulators of BCSCs opens new directions for advancing BC research through the use of bioinformatics and the development of innovative therapeutic approaches. This review summarizes the most recent and innovative studies and clinical trials on the role of BCSCs miRNAs as potential tools for early diagnosis, prognosis, and resistance. |
Audience | Academic |
Author | Marchal, Juan Antonio Heredia-Nicolás, Noelia Nogueras Pérez, Raquel Griñán-Lisón, Carmen de Lara-Peña, Laura Jiménez, Gema López de Andrés, Julia |
Author_xml | – sequence: 1 fullname: Nogueras Pérez, Raquel – sequence: 2 fullname: Heredia-Nicolás, Noelia – sequence: 3 fullname: de Lara-Peña, Laura – sequence: 4 fullname: López de Andrés, Julia – sequence: 5 fullname: Marchal, Juan Antonio – sequence: 6 fullname: Jiménez, Gema – sequence: 7 fullname: Griñán-Lisón, Carmen |
BookMark | eNptks9rFTEQxxepYFs9eg948bI1P3aTzfG5Vi0ULdqew2x2suaxm9Rkn-B_b9Yn0ookkMnw-X6HYeasOgkxYFW9ZPRCCE3f-P2SecMZk5TRJ9UpazivKZXq5EH8rDrLeU8pF7zVp1W-Cwl-4OzDRNZvSG7iimH1MJPoyOK_fNpl4lJcSP-1zwTKDeRywTRtgr7IvC3sbYwzcTGRtwkhr6SHYDGRdx6mELPfVCO5SfH4e149dTBnfPHnPa_u3l_e9h_r688frvrddW0bRde60QLECK1ENiqpRgeNw2boAMFa3XIp0XXCWmi1o5KPdGipUtwq7VAMVonz6uroO0bYm_vkF0g_TQRvfidimgyk1dsZDTCQsums4KNqWtTDOGhupQIqBxiYKF6vj173KX4_YF7N4rPFeYaA8ZAN7zqtNS9zKOirf9B9PKRQOt2ojrVtox9QE5T6Pri4JrCbqdmVLlohBN_KXvyHKmfExdsyfudL_pGgPgpsijkndH_7ZtRsW2IebYn4BZlwr98 |
CitedBy_id | crossref_primary_10_1007_s12011_024_04274_6 crossref_primary_10_2174_0118715206293653240322041047 |
Cites_doi | 10.1111/jcmm.15317 10.1016/j.cmet.2016.12.018 10.1002/ijc.27727 10.1101/cshperspect.a022079 10.1016/j.ncrna.2022.12.005 10.1111/cpr.12146 10.1158/0008-5472.CAN-05-1783 10.1186/s13045-017-0471-6 10.3892/mmr.2017.7443 10.2174/1574887112666170202165049 10.1631/jzus.B1900709 10.1038/onc.2010.531 10.1074/jbc.M111.227611 10.1093/nar/gkac363 10.1038/s41580-018-0015-0 10.7554/eLife.01977 10.1038/s41467-018-04760-1 10.3109/09553002.2014.892227 10.1371/journal.pone.0039102 10.1158/0008-5472.CAN-14-1140 10.1016/j.bbrc.2015.08.053 10.1038/sj.onc.1210083 10.3892/ol.2013.1593 10.1038/nrrheum.2015.167 10.1016/j.cmet.2019.01.015 10.1016/j.cmet.2017.11.001 10.1016/j.bbagen.2012.11.008 10.1371/journal.pone.0153194 10.3892/mmr.2016.5656 10.1016/j.ajpath.2013.07.002 10.1016/j.critrevonc.2010.01.011 10.1038/s41467-020-19103-2 10.18632/oncotarget.5873 10.1371/journal.pone.0041462 10.1016/j.gene.2017.01.036 10.1002/mnfr.201200549 10.1002/jcla.23887 10.3892/or.2015.4160 10.1007/s11010-011-0755-z 10.7150/jca.12351 10.1016/j.molcel.2017.06.033 10.1016/j.semcancer.2017.08.010 10.1158/0008-5472.CAN-12-1507 10.18632/aging.102719 10.1373/clinchem.2016.267161 10.1007/s12282-018-0926-9 10.1186/s13046-021-01901-1 10.1371/journal.pone.0192509 10.1093/nar/gky1141 10.3389/fcell.2021.741074 10.1038/onc.2014.180 10.1016/j.gene.2016.10.016 10.1093/nar/gkaa452 10.1093/bib/bby054 10.1038/s41573-022-00579-0 10.1007/s10555-017-9712-y 10.1016/j.omto.2020.05.011 10.18632/aging.203298 10.1093/nar/gky985 10.1530/JME-15-0182 10.1016/j.suronc.2009.01.004 10.1007/s12291-018-0766-6 10.7150/thno.29380 10.1186/s12935-020-01716-8 10.1016/j.molcel.2010.12.005 10.15252/embr.201540678 10.1016/S0140-6736(16)31891-8 10.1631/jzus.B1400184 10.1186/s43141-021-00174-7 10.2147/OTT.S165156 10.3892/or.2012.1634 10.3390/ijms22116121 10.1002/jcp.26399 10.1016/j.lungcan.2013.05.007 10.1038/srep39782 10.3390/ijms22073756 10.1371/journal.pone.0039520 10.3892/or.2017.5393 10.1016/j.ebiom.2016.08.016 10.1111/febs.13543 10.4048/jbc.2018.21.e56 10.1007/s13277-015-4402-2 10.3389/fmolb.2021.668534 10.1002/jcp.29044 10.3892/or.2015.4502 10.1038/s41388-018-0239-7 10.1373/clinchem.2015.238691 10.1096/fj.201600428R 10.1016/j.intimp.2020.106535 10.1515/hsz-2016-0104 10.1186/s12885-019-5951-3 10.1080/15384047.2018.1529101 10.1007/s13402-015-0236-6 10.18632/oncotarget.4921 10.3390/ijms222011135 10.1074/jbc.M112.419168 10.1371/journal.pgen.1002751 10.7150/thno.11543 10.1016/j.bbagen.2013.01.009 10.1038/srep28329 10.4252/wjsc.v6.i5.591 10.3390/diagnostics12030745 10.1038/cgt.2016.3 10.1016/j.ncrna.2022.09.003 10.1172/JCI45014 10.1186/s13058-020-01296-5 10.4103/jcrt.JCRT_1227_16 10.1177/1010428318791887 10.1038/s41419-020-2399-y 10.1007/s10549-014-3079-3 10.1016/j.cbi.2017.08.014 10.1080/13813455.2019.1616765 10.1200/JCO.2010.31.2835 10.3390/ijms21165834 10.1634/theoncologist.9-6-606 10.1186/1476-4598-9-12 10.3390/ncrna5040053 10.1634/theoncologist.2018-0697 10.1261/rna.034926.112 10.1016/j.cell.2011.02.013 10.1038/cr.2008.24 10.1038/s41598-018-36321-3 10.4174/astr.2017.92.2.55 10.3389/fonc.2021.696269 10.1016/j.trsl.2014.10.001 10.1177/1758834015608993 10.1002/stem.1795 10.18632/oncotarget.15960 10.3390/molecules21030290 10.1038/ncb1681 10.1111/cas.13588 10.3892/ijo.2015.3287 10.1016/j.celrep.2017.02.016 10.1615/CritRevEukaryotGeneExpr.2023046030 10.1016/j.amjsurg.2016.03.016 10.1002/pmic.201600375 10.1038/ncb1722 10.1002/mgg3.1092 10.1186/s12964-020-00700-z |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 DOA |
DOI | 10.3390/ijms242116010 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest_Research Library Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | oai_doaj_org_article_a1a6648c32d745e9bdb92c67a06bab13 A772533323 10_3390_ijms242116010 |
GeographicLocations | Canada Spain |
GeographicLocations_xml | – name: Canada – name: Spain |
GroupedDBID | --- 29J 2WC 3V. 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV AEAQA AENEX AFKRA AFPKN AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESTFP ESX F5P FRP FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HH5 HMCUK HYE IAO ITC KB. KQ8 LK8 M1P M2O M48 M7P MODMG M~E O5R O5S OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M BGLVJ 7XB 8FK K9. MBDVC PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c470t-493a3da56e1d767dfa4fe4b8aeacc95266ef83cca59f062d0b50772c79fe3bc73 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Tue Oct 22 15:14:33 EDT 2024 Fri Oct 25 21:22:05 EDT 2024 Thu Oct 10 14:59:48 EDT 2024 Fri Feb 23 00:20:52 EST 2024 Fri Feb 02 04:37:19 EST 2024 Fri Aug 23 00:56:23 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c470t-493a3da56e1d767dfa4fe4b8aeacc95266ef83cca59f062d0b50772c79fe3bc73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0009-0000-4306-7465 0000-0002-4996-8261 0000-0002-9803-879X |
OpenAccessLink | https://www.proquest.com/docview/2888155499?pq-origsite=%requestingapplication% |
PQID | 2888155499 |
PQPubID | 2032341 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a1a6648c32d745e9bdb92c67a06bab13 proquest_miscellaneous_2889992339 proquest_journals_2888155499 gale_infotracmisc_A772533323 gale_infotracacademiconefile_A772533323 crossref_primary_10_3390_ijms242116010 |
PublicationCentury | 2000 |
PublicationDate | 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationYear | 2023 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Pentimalli (ref_27) 2017; 8 ref_138 Moskwa (ref_71) 2011; 41 Abbas (ref_76) 2022; 7 Wang (ref_73) 2015; 16 ref_99 ref_133 Saeidi (ref_91) 2018; 12 ref_132 Shen (ref_43) 2017; 596 ref_96 ref_135 Yang (ref_114) 2021; 40 Atashzar (ref_8) 2020; 235 ref_18 Nicolini (ref_92) 2018; 52 Krishnan (ref_70) 2013; 19 Pai (ref_54) 2017; 10 Folini (ref_79) 2010; 9 Sun (ref_127) 2016; 14 Cuzick (ref_15) 2011; 29 Liu (ref_82) 2013; 25 Markou (ref_65) 2013; 81 ref_125 Si (ref_80) 2007; 26 Zheng (ref_140) 2012; 27 Maldonado (ref_60) 2015; 38 ref_24 Filho (ref_13) 2011; 77 ref_20 Khalighfard (ref_86) 2018; 8 ref_124 Cianfrocca (ref_14) 2004; 9 Boulaiz (ref_17) 2017; 7 Vardhana (ref_9) 2019; 29 Samuel (ref_119) 2017; 17 Bai (ref_90) 2018; 16 Giannoukakos (ref_143) 2020; 48 Chuthapisith (ref_12) 2010; 19 Han (ref_64) 2017; 92 Bertoli (ref_67) 2015; 5 Harbeck (ref_1) 2017; 389 Yin (ref_7) 2020; 22 Sun (ref_30) 2016; 23 Swellam (ref_72) 2021; 127 Li (ref_89) 2017; 16 Shen (ref_105) 2021; 19 Rouigari (ref_111) 2019; 34 Iorio (ref_107) 2005; 65 Mak (ref_53) 2013; 57 Verzella (ref_61) 2020; 11 ref_75 Salajegheh (ref_130) 2015; 55 Shen (ref_58) 2018; 9 Lehmann (ref_6) 2011; 121 Liu (ref_36) 2016; 6 Wang (ref_68) 2013; 6 Liu (ref_97) 2019; 26 Eissa (ref_87) 2015; 165 Fung (ref_93) 2017; 213 Lu (ref_98) 2020; 18 Liu (ref_32) 2015; 6 Wu (ref_52) 2016; 283 Andrianifahanana (ref_10) 2016; 30 Karamboulas (ref_57) 2013; 1830 Kozomara (ref_141) 2019; 47 Wu (ref_134) 2015; 6 Liu (ref_145) 2019; 47 Seok (ref_126) 2023; 8 Lee (ref_117) 2018; 109 Aalami (ref_136) 2020; 2020 Wolfson (ref_23) 2014; 6 Chen (ref_28) 2020; 24 Shui (ref_39) 2017; 609 Zhang (ref_42) 2018; 11 Lv (ref_26) 2020; 11 Yan (ref_46) 2016; 48 Xu (ref_139) 2020; 21 Huang (ref_74) 2008; 10 Matamala (ref_84) 2015; 61 Ahn (ref_16) 2013; 132 Rycaj (ref_115) 2014; 90 Gregory (ref_131) 2008; 10 Reinert (ref_3) 2015; 7 Chen (ref_85) 2016; 7 Li (ref_83) 2020; 8 Xiao (ref_88) 2019; 42 Wang (ref_49) 2011; 30 Yang (ref_48) 2014; 47 Wang (ref_33) 2017; 37 Pourteimoor (ref_101) 2018; 233 ref_66 Wang (ref_77) 2011; 352 Mao (ref_120) 2016; 37 Espinosa (ref_47) 2016; 17 Zhao (ref_121) 2021; 13 Yu (ref_100) 2018; 21 Cheng (ref_123) 2019; 20 Dar (ref_129) 2011; 286 Guarnieri (ref_102) 2018; 37 Gong (ref_113) 2016; 11 Gade (ref_137) 2014; 147 Dwedar (ref_108) 2021; 35 Jiang (ref_22) 2016; 35 Liu (ref_31) 2013; 288 Li (ref_44) 2017; 277 Liu (ref_29) 2018; 8 ref_118 Liu (ref_41) 2021; 11 ref_35 Niu (ref_78) 2021; 21 Tan (ref_103) 2019; 24 Wuerstlein (ref_4) 2017; 12 Zhu (ref_34) 2016; 397 ref_110 ref_112 Lee (ref_59) 2018; 19 Angelin (ref_11) 2017; 25 Deng (ref_56) 2015; 34 Chen (ref_142) 2019; 20 Schwartz (ref_55) 2016; 12 Hanahan (ref_116) 2011; 144 Swain (ref_5) 2023; 22 Isobe (ref_25) 2014; 3 Barzaman (ref_2) 2020; 84 Hou (ref_122) 2019; 17 Duffy (ref_95) 2017; 63 Giannoukakos (ref_144) 2022; 50 Kim (ref_106) 2018; 37 Zhang (ref_40) 2015; 465 Fan (ref_94) 2023; 33 Pinna (ref_21) 2017; 18 ref_109 Soleimanpour (ref_62) 2019; 15 ref_45 Yoon (ref_19) 2017; 67 Zhang (ref_37) 2014; 32 Wells (ref_63) 2013; 183 Qian (ref_50) 2012; 72 Park (ref_38) 2014; 74 Wang (ref_128) 2018; 27 Wang (ref_104) 2020; 12 Chiang (ref_69) 2013; 1830 Kastrati (ref_51) 2015; 34 Zhu (ref_81) 2008; 18 |
References_xml | – volume: 24 start-page: 7353 year: 2020 ident: ref_28 article-title: microRNA-128-3p Overexpression Inhibits Breast Cancer Stem Cell Characteristics through Suppression of Wnt Signalling Pathway by Down-regulating NEK2 publication-title: J. Cell. Mol. Medi doi: 10.1111/jcmm.15317 contributor: fullname: Chen – volume: 12 start-page: 3 year: 2018 ident: ref_91 article-title: Evaluation of Circulating miRNA146a, miRNA155 and miRNA373 as Potential Biomarkers in Ovarian Cancer Detection publication-title: J. Mol. Genet. Med. contributor: fullname: Saeidi – volume: 25 start-page: 1282 year: 2017 ident: ref_11 article-title: Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments publication-title: Cell Metab. doi: 10.1016/j.cmet.2016.12.018 contributor: fullname: Angelin – volume: 132 start-page: 875 year: 2013 ident: ref_16 article-title: Preoperative Serum Tissue Polypeptide-Specific Antigen Is a Valuable Prognostic Marker in Breast Cancer publication-title: Int. J. Cancer doi: 10.1002/ijc.27727 contributor: fullname: Ahn – ident: ref_18 doi: 10.1101/cshperspect.a022079 – volume: 8 start-page: 164 year: 2023 ident: ref_126 article-title: Targeting miR-5088-5p Attenuates Radioresistance by Suppressing Slug publication-title: Noncoding RNA Res. doi: 10.1016/j.ncrna.2022.12.005 contributor: fullname: Seok – volume: 47 start-page: 587 year: 2014 ident: ref_48 article-title: miR-99a Directly Targets the mTOR Signalling Pathway in Breast Cancer Side Population Cells publication-title: Cell Prolif. doi: 10.1111/cpr.12146 contributor: fullname: Yang – volume: 65 start-page: 7065 year: 2005 ident: ref_107 article-title: MicroRNA Gene Expression Deregulation in Human Breast Cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-1783 contributor: fullname: Iorio – volume: 10 start-page: 101 year: 2017 ident: ref_54 article-title: Wnt/Beta-Catenin Pathway: Modulating Anticancer Immune Response publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-017-0471-6 contributor: fullname: Pai – volume: 16 start-page: 7048 year: 2017 ident: ref_89 article-title: MicroRNA-373 Promotes Tumorigenesis of Renal Cell Carcinoma in Vitro and in Vivo publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.7443 contributor: fullname: Li – volume: 12 start-page: 81 year: 2017 ident: ref_4 article-title: Neoadjuvant Therapy for HER2-Positive Breast Cancer publication-title: RRCT doi: 10.2174/1574887112666170202165049 contributor: fullname: Wuerstlein – volume: 21 start-page: 673 year: 2020 ident: ref_139 article-title: Roles of miRNA and lncRNA in Triple-Negative Breast Cancer publication-title: J. Zhejiang Univ. Sci. B doi: 10.1631/jzus.B1900709 contributor: fullname: Xu – volume: 30 start-page: 1470 year: 2011 ident: ref_49 article-title: Transforming Growth Factor-β Regulates the Sphere-Initiating Stem Cell-like Feature in Breast Cancer through miRNA-181 and ATM publication-title: Oncogene doi: 10.1038/onc.2010.531 contributor: fullname: Wang – volume: 286 start-page: 16606 year: 2011 ident: ref_129 article-title: miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.227611 contributor: fullname: Dar – volume: 50 start-page: W710 year: 2022 ident: ref_144 article-title: sRNAbench and sRNAtoolbox 2022 Update: Accurate miRNA and sncRNA Profiling for Model and Non-Model Organisms publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac363 contributor: fullname: Giannoukakos – volume: 19 start-page: 547 year: 2018 ident: ref_59 article-title: The Functions and Regulation of the PTEN Tumour Suppressor: New Modes and Prospects publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-018-0015-0 contributor: fullname: Lee – volume: 3 start-page: e01977 year: 2014 ident: ref_25 article-title: miR-142 Regulates the Tumorigenicity of Human Breast Cancer Stem Cells through the Canonical WNT Signaling Pathway publication-title: eLife doi: 10.7554/eLife.01977 contributor: fullname: Isobe – volume: 9 start-page: 2392 year: 2018 ident: ref_58 article-title: Nuclear PTEN Safeguards Pre-mRNA Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role publication-title: Nat. Commun. doi: 10.1038/s41467-018-04760-1 contributor: fullname: Shen – volume: 90 start-page: 615 year: 2014 ident: ref_115 article-title: Cancer Stem Cells and Radioresistance publication-title: Int. J. Radiat. Biol. doi: 10.3109/09553002.2014.892227 contributor: fullname: Rycaj – ident: ref_135 doi: 10.1371/journal.pone.0039102 – volume: 74 start-page: 7573 year: 2014 ident: ref_38 article-title: Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-1140 contributor: fullname: Park – volume: 465 start-page: 702 year: 2015 ident: ref_40 article-title: MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.08.053 contributor: fullname: Zhang – volume: 26 start-page: 2799 year: 2007 ident: ref_80 article-title: miR-21-Mediated Tumor Growth publication-title: Oncogene doi: 10.1038/sj.onc.1210083 contributor: fullname: Si – volume: 6 start-page: 1681 year: 2013 ident: ref_68 article-title: Higher Expression of Circulating miR-182 as a Novel Biomarker for Breast Cancer publication-title: Oncol. Lett. doi: 10.3892/ol.2013.1593 contributor: fullname: Wang – volume: 12 start-page: 25 year: 2016 ident: ref_55 article-title: Type I/II Cytokines, JAKs, and New Strategies for Treating Autoimmune Diseases publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2015.167 contributor: fullname: Schwartz – volume: 29 start-page: 576 year: 2019 ident: ref_9 article-title: Cancer Metabolism Drives a Stromal Regenerative Response publication-title: Cell Metab. doi: 10.1016/j.cmet.2019.01.015 contributor: fullname: Vardhana – volume: 27 start-page: 136 year: 2018 ident: ref_128 article-title: JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.11.001 contributor: fullname: Wang – volume: 1830 start-page: 2481 year: 2013 ident: ref_57 article-title: Developmental Signaling Pathways in Cancer Stem Cells of Solid Tumors publication-title: Biochim. Biophys. Acta (BBA)—Gen. Subj. doi: 10.1016/j.bbagen.2012.11.008 contributor: fullname: Karamboulas – ident: ref_24 doi: 10.1371/journal.pone.0153194 – volume: 14 start-page: 3285 year: 2016 ident: ref_127 article-title: Let-7 miRNAs Sensitize Breast Cancer Stem Cells to Radiation-Induced Repression through Inhibition of the Cyclin D1/Akt1/Wnt1 Signaling Pathway publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2016.5656 contributor: fullname: Sun – volume: 183 start-page: 1075 year: 2013 ident: ref_63 article-title: The Emerging Role of the Molecular Diagnostics Laboratory in Breast Cancer Personalized Medicine publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2013.07.002 contributor: fullname: Wells – volume: 77 start-page: 20 year: 2011 ident: ref_13 article-title: Genomic Grade Index: An Important Tool for Assessing Breast Cancer Tumor Grade and Prognosis publication-title: Crit. Rev. Oncol./Hematol. doi: 10.1016/j.critrevonc.2010.01.011 contributor: fullname: Filho – volume: 11 start-page: 5308 year: 2020 ident: ref_26 article-title: Author Correction: MiR-31 Promotes Mammary Stem Cell Expansion and Breast Tumorigenesis by Suppressing Wnt Signaling Antagonists publication-title: Nat. Commun. doi: 10.1038/s41467-020-19103-2 contributor: fullname: Lv – volume: 6 start-page: 41638 year: 2015 ident: ref_32 article-title: MicroRNA-1 down-Regulates Proliferation and Migration of Breast Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Pathway publication-title: Oncotarget doi: 10.18632/oncotarget.5873 contributor: fullname: Liu – ident: ref_132 doi: 10.1371/journal.pone.0041462 – volume: 609 start-page: 80 year: 2017 ident: ref_39 article-title: miR-130b-3p Inhibits Cell Invasion and Migration by Targeting the Notch Ligand Delta-like 1 in Breast Carcinoma publication-title: Gene doi: 10.1016/j.gene.2017.01.036 contributor: fullname: Shui – volume: 16 start-page: 4759 year: 2018 ident: ref_90 article-title: MicroRNA-373 Promotes Cell Migration via Targeting Salt-Inducible Kinase 1 Expression in Melanoma publication-title: Exp. Ther. Med. contributor: fullname: Bai – volume: 57 start-page: 1123 year: 2013 ident: ref_53 article-title: Pterostilbene, a Bioactive Component of Blueberries, Suppresses the Generation of Breast Cancer Stem Cells within Tumor Microenvironment and Metastasis via Modulating NF-κB/microRNA 448 Circuit publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201200549 contributor: fullname: Mak – volume: 35 start-page: e23887 year: 2021 ident: ref_108 article-title: Potential Value of Circulatory microRNA10b Gene Expression and Its Target E-Cadherin as a Prognostic and Metastatic Prediction Marker for Breast Cancer publication-title: J. Clin. Lab. Anal. doi: 10.1002/jcla.23887 contributor: fullname: Dwedar – volume: 34 start-page: 2188 year: 2015 ident: ref_56 article-title: miR-519d-Mediated Downregulation of STAT3 Suppresses Breast Cancer Progression publication-title: Oncol. Rep. doi: 10.3892/or.2015.4160 contributor: fullname: Deng – volume: 352 start-page: 197 year: 2011 ident: ref_77 article-title: miR-29b Regulates Migration of Human Breast Cancer Cells publication-title: Mol. Cell Biochem. doi: 10.1007/s11010-011-0755-z contributor: fullname: Wang – volume: 7 start-page: 490 year: 2016 ident: ref_85 article-title: Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers publication-title: J. Cancer doi: 10.7150/jca.12351 contributor: fullname: Chen – volume: 67 start-page: 512 year: 2017 ident: ref_19 article-title: Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition publication-title: Mol. Cell doi: 10.1016/j.molcel.2017.06.033 contributor: fullname: Yoon – volume: 52 start-page: 56 year: 2018 ident: ref_92 article-title: Prognostic and Predictive Biomarkers in Breast Cancer: Past, Present and Future publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2017.08.010 contributor: fullname: Nicolini – volume: 72 start-page: 6036 year: 2012 ident: ref_50 article-title: Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-1507 contributor: fullname: Qian – volume: 12 start-page: 1867 year: 2020 ident: ref_104 article-title: miR-106b-5p Contributes to the Lung Metastasis of Breast Cancer via Targeting CNN1 and Regulating Rho/ROCK1 Pathway publication-title: Aging doi: 10.18632/aging.102719 contributor: fullname: Wang – volume: 63 start-page: 804 year: 2017 ident: ref_95 article-title: Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy publication-title: Clin. Chem. doi: 10.1373/clinchem.2016.267161 contributor: fullname: Duffy – volume: 26 start-page: 317 year: 2019 ident: ref_97 article-title: Identification of Genes Associated with Survival of Breast Cancer Patients publication-title: Breast Cancer doi: 10.1007/s12282-018-0926-9 contributor: fullname: Liu – volume: 40 start-page: 120 year: 2021 ident: ref_114 article-title: Chemotherapy-Elicited Exosomal miR-378a-3p and miR-378d Promote Breast Cancer Stemness and Chemoresistance via the Activation of EZH2/STAT3 Signaling publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-021-01901-1 contributor: fullname: Yang – ident: ref_109 doi: 10.1371/journal.pone.0192509 – volume: 47 start-page: D155 year: 2019 ident: ref_141 article-title: miRBase: From microRNA Sequences to Function publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1141 contributor: fullname: Kozomara – ident: ref_125 doi: 10.3389/fcell.2021.741074 – volume: 34 start-page: 2309 year: 2015 ident: ref_51 article-title: PHLDA1 Expression Is Controlled by an Estrogen Receptor-NFκB-miR-181 Regulatory Loop and Is Essential for Formation of ER+ Mammospheres publication-title: Oncogene doi: 10.1038/onc.2014.180 contributor: fullname: Kastrati – volume: 596 start-page: 110 year: 2017 ident: ref_43 article-title: MiR-222 Promotes Drug-Resistance of Breast Cancer Cells to Adriamycin via Modulation of PTEN/Akt/FOXO1 Pathway publication-title: Gene doi: 10.1016/j.gene.2016.10.016 contributor: fullname: Shen – volume: 48 start-page: W262 year: 2020 ident: ref_143 article-title: mirnaQC: A Webserver for Comparative Quality Control of miRNA-Seq Data publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkaa452 contributor: fullname: Giannoukakos – volume: 20 start-page: 1836 year: 2019 ident: ref_142 article-title: Trends in the Development of miRNA Bioinformatics Tools publication-title: Brief. Bioinform. doi: 10.1093/bib/bby054 contributor: fullname: Chen – volume: 25 start-page: 46 year: 2013 ident: ref_82 article-title: Analysis of miR-205 and miR-155 Expression in the Blood of Breast Cancer Patients publication-title: Chin. J. Cancer Res. contributor: fullname: Liu – volume: 22 start-page: 101 year: 2023 ident: ref_5 article-title: Targeting HER2-Positive Breast Cancer: Advances and Future Directions publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-022-00579-0 contributor: fullname: Swain – volume: 37 start-page: 5 year: 2018 ident: ref_106 article-title: MicroRNAs and Metastasis: Small RNAs Play Big Roles publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-017-9712-y contributor: fullname: Kim – volume: 18 start-page: 47 year: 2020 ident: ref_98 article-title: Hypomethylation Causes MIR21 Overexpression in Tumors publication-title: Mol. Ther.-Oncolytics doi: 10.1016/j.omto.2020.05.011 contributor: fullname: Lu – volume: 13 start-page: 18498 year: 2021 ident: ref_121 article-title: Exosomal miRNA-205 Promotes Breast Cancer Chemoresistance and Tumorigenesis through E2F1 publication-title: Aging doi: 10.18632/aging.203298 contributor: fullname: Zhao – volume: 47 start-page: D89 year: 2019 ident: ref_145 article-title: EVmiRNA: A Database of miRNA Profiling in Extracellular Vesicles publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky985 contributor: fullname: Liu – volume: 55 start-page: 183 year: 2015 ident: ref_130 article-title: Modulatory Role of miR-205 in Angiogenesis and Progression of Thyroid Cancer publication-title: J. Mol. Endocrinol. doi: 10.1530/JME-15-0182 contributor: fullname: Salajegheh – volume: 19 start-page: 27 year: 2010 ident: ref_12 article-title: Breast Cancer Chemoresistance: Emerging Importance of Cancer Stem Cells publication-title: Surg. Oncol. doi: 10.1016/j.suronc.2009.01.004 contributor: fullname: Chuthapisith – volume: 34 start-page: 451 year: 2019 ident: ref_111 article-title: Evaluation of the Expression Level and Hormone Receptor Association of miR-126 in Breast Cancer publication-title: Indian. J. Clin. Biochem. doi: 10.1007/s12291-018-0766-6 contributor: fullname: Rouigari – volume: 8 start-page: 5801 year: 2018 ident: ref_29 article-title: miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis publication-title: Theranostics doi: 10.7150/thno.29380 contributor: fullname: Liu – volume: 21 start-page: 31 year: 2021 ident: ref_78 article-title: MicroRNA Regulation of Cancer Stem Cells in the Pathogenesis of Breast Cancer publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-01716-8 contributor: fullname: Niu – volume: 41 start-page: 210 year: 2011 ident: ref_71 article-title: miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.12.005 contributor: fullname: Moskwa – volume: 17 start-page: 648 year: 2016 ident: ref_47 article-title: miR-10b Expression in Breast Cancer Stem Cells Supports Self-Renewal through Negative PTEN Regulation and Sustained AKT Activation publication-title: EMBO Rep. doi: 10.15252/embr.201540678 contributor: fullname: Espinosa – volume: 389 start-page: 1134 year: 2017 ident: ref_1 article-title: Breast Cancer publication-title: Lancet doi: 10.1016/S0140-6736(16)31891-8 contributor: fullname: Harbeck – volume: 16 start-page: 18 year: 2015 ident: ref_73 article-title: MicroRNAs in Breast Cancer: Oncogene and Tumor Suppressors with Clinical Potential publication-title: J. Zhejiang Univ. Sci. B doi: 10.1631/jzus.B1400184 contributor: fullname: Wang – ident: ref_75 doi: 10.1186/s43141-021-00174-7 – volume: 11 start-page: 4263 year: 2018 ident: ref_42 article-title: Effects of miRNAs on Functions of Breast Cancer Stem Cells and Treatment of Breast Cancer publication-title: OncoTargets Ther. doi: 10.2147/OTT.S165156 contributor: fullname: Zhang – volume: 27 start-page: 1149 year: 2012 ident: ref_140 article-title: Clinical Significance of miR-155 Expression in Breast Cancer and Effects of miR-155 ASO on Cell Viability and Apoptosis publication-title: Oncol. Rep. doi: 10.3892/or.2012.1634 contributor: fullname: Zheng – ident: ref_66 doi: 10.3390/ijms22116121 – volume: 233 start-page: 5655 year: 2018 ident: ref_101 article-title: microRNA as a Systemic Intervention in the Specific Breast Cancer Subtypes with C-MYC Impacts; Introducing Subtype-based Appraisal Tool publication-title: J. Cell. Physiol. doi: 10.1002/jcp.26399 contributor: fullname: Pourteimoor – volume: 81 start-page: 388 year: 2013 ident: ref_65 article-title: Clinical Evaluation of microRNA Expression Profiling in Non Small Cell Lung Cancer publication-title: Lung Cancer doi: 10.1016/j.lungcan.2013.05.007 contributor: fullname: Markou – volume: 7 start-page: 39782 year: 2017 ident: ref_17 article-title: Validation of Suitable Normalizers for miR Expression Patterns Analysis Covering Tumour Heterogeneity publication-title: Sci. Rep. doi: 10.1038/srep39782 contributor: fullname: Boulaiz – ident: ref_20 doi: 10.3390/ijms22073756 – ident: ref_45 doi: 10.1371/journal.pone.0039520 – volume: 37 start-page: 1537 year: 2017 ident: ref_33 article-title: miR520c Blocks EMT Progression of Human Breast Cancer Cells by Repressing STAT3 publication-title: Oncol. Rep. doi: 10.3892/or.2017.5393 contributor: fullname: Wang – volume: 11 start-page: 199 year: 2016 ident: ref_113 article-title: Prognostic Value of a BCSC-Associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer publication-title: eBioMedicine doi: 10.1016/j.ebiom.2016.08.016 contributor: fullname: Gong – volume: 283 start-page: 2259 year: 2016 ident: ref_52 article-title: A Negative Feedback Loop between miR-200b and the Nuclear factor-κB Pathway via IKBKB/IKK -β in Breast Cancer Cells publication-title: FEBS J. doi: 10.1111/febs.13543 contributor: fullname: Wu – volume: 21 start-page: 363 year: 2018 ident: ref_100 article-title: Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data publication-title: J. Breast Cancer doi: 10.4048/jbc.2018.21.e56 contributor: fullname: Yu – volume: 37 start-page: 5247 year: 2016 ident: ref_120 article-title: Exosomes Decrease Sensitivity of Breast Cancer Cells to Adriamycin by Delivering microRNAs publication-title: Tumor Biol. doi: 10.1007/s13277-015-4402-2 contributor: fullname: Mao – ident: ref_112 doi: 10.3389/fmolb.2021.668534 – volume: 235 start-page: 790 year: 2020 ident: ref_8 article-title: Cancer Stem Cells: A Review from Origin to Therapeutic Implications publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29044 contributor: fullname: Atashzar – volume: 35 start-page: 1425 year: 2016 ident: ref_22 article-title: MicroRNA-148a Inhibits Breast Cancer Migration and Invasion by Directly Targeting WNT-1 publication-title: Oncol. Rep. doi: 10.3892/or.2015.4502 contributor: fullname: Jiang – volume: 37 start-page: 3879 year: 2018 ident: ref_102 article-title: The miR-106b-25 Cluster Mediates Breast Tumor Initiation through Activation of NOTCH1 via Direct Repression of NEDD4L publication-title: Oncogene doi: 10.1038/s41388-018-0239-7 contributor: fullname: Guarnieri – volume: 61 start-page: 1098 year: 2015 ident: ref_84 article-title: Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection publication-title: Clin. Chem. doi: 10.1373/clinchem.2015.238691 contributor: fullname: Matamala – volume: 30 start-page: 3733 year: 2016 ident: ref_10 article-title: Profibrotic Up-regulation of Glucose Transporter 1 by TGF-β Involves Activation of MEK and Mammalian Target of Rapamycin Complex 2 Pathways publication-title: FASEB J. doi: 10.1096/fj.201600428R contributor: fullname: Andrianifahanana – volume: 42 start-page: 2550 year: 2019 ident: ref_88 article-title: miR-425-5p Is Associated with Poor Prognosis in Patients with Breast Cancer and Promotes Cancer Cell Progression by Targeting PTEN publication-title: Oncol. Rep. contributor: fullname: Xiao – volume: 84 start-page: 106535 year: 2020 ident: ref_2 article-title: Breast Cancer: Biology, Biomarkers, and Treatments publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2020.106535 contributor: fullname: Barzaman – volume: 397 start-page: 1087 year: 2016 ident: ref_34 article-title: MicroRNA-544 down-Regulates Both Bcl6 and Stat3 to Inhibit Tumor Growth of Human Triple Negative Breast Cancer publication-title: Biol. Chem. doi: 10.1515/hsz-2016-0104 contributor: fullname: Zhu – ident: ref_99 doi: 10.1186/s12885-019-5951-3 – volume: 20 start-page: 328 year: 2019 ident: ref_123 article-title: FSTL1 Enhances Chemoresistance and Maintains Stemness in Breast Cancer Cells via Integrin Β3/Wnt Signaling under miR-137 Regulation publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2018.1529101 contributor: fullname: Cheng – volume: 38 start-page: 327 year: 2015 ident: ref_60 article-title: NF-κB Signaling in Cancer Stem Cells: A Promising Therapeutic Target? publication-title: Cell Oncol. doi: 10.1007/s13402-015-0236-6 contributor: fullname: Maldonado – volume: 6 start-page: 28882 year: 2015 ident: ref_134 article-title: MiR-1207 Overexpression Promotes Cancer Stem Cell-like Traits in Ovarian Cancer by Activating the Wnt/β-Catenin Signaling Pathway publication-title: Oncotarget doi: 10.18632/oncotarget.4921 contributor: fullname: Wu – ident: ref_96 doi: 10.3390/ijms222011135 – volume: 288 start-page: 4334 year: 2013 ident: ref_31 article-title: miR-125b Functions as a Key Mediator for Snail-Induced Stem Cell Propagation and Chemoresistance publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.419168 contributor: fullname: Liu – ident: ref_35 doi: 10.1371/journal.pgen.1002751 – volume: 5 start-page: 1122 year: 2015 ident: ref_67 article-title: MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer publication-title: Theranostics doi: 10.7150/thno.11543 contributor: fullname: Bertoli – volume: 1830 start-page: 3067 year: 2013 ident: ref_69 article-title: Up-Regulation of miR-182 by β-Catenin in Breast Cancer Increases Tumorigenicity and Invasiveness by Targeting the Matrix Metalloproteinase Inhibitor RECK publication-title: Biochim. et Biophys. Acta (BBA)—Gen. Subj. doi: 10.1016/j.bbagen.2013.01.009 contributor: fullname: Chiang – volume: 6 start-page: 28329 year: 2016 ident: ref_36 article-title: EMMPRIN Down-Regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α publication-title: Sci. Rep. doi: 10.1038/srep28329 contributor: fullname: Liu – volume: 6 start-page: 591 year: 2014 ident: ref_23 article-title: Roles of microRNA-140 in Stem Cell-Associated Early Stage Breast Cancer publication-title: World J. Stem Cells doi: 10.4252/wjsc.v6.i5.591 contributor: fullname: Wolfson – ident: ref_110 doi: 10.3390/diagnostics12030745 – volume: 23 start-page: 83 year: 2016 ident: ref_30 article-title: Let-7c Blocks Estrogen-Activated Wnt Signaling in Induction of Self-Renewal of Breast Cancer Stem Cells publication-title: Cancer Gene Ther. doi: 10.1038/cgt.2016.3 contributor: fullname: Sun – volume: 7 start-page: 248 year: 2022 ident: ref_76 article-title: Expression of MiRNA-29b and MiRNA-31 and Their Diagnostic and Prognostic Values in Egyptian Females with Breast Cancer publication-title: Non-Coding RNA Res. doi: 10.1016/j.ncrna.2022.09.003 contributor: fullname: Abbas – volume: 121 start-page: 2750 year: 2011 ident: ref_6 article-title: Identification of Human Triple-Negative Breast Cancer Subtypes and Preclinical Models for Selection of Targeted Therapies publication-title: J. Clin. Investig. doi: 10.1172/JCI45014 contributor: fullname: Lehmann – volume: 22 start-page: 61 year: 2020 ident: ref_7 article-title: Triple-Negative Breast Cancer Molecular Subtyping and Treatment Progress publication-title: Breast Cancer Res. doi: 10.1186/s13058-020-01296-5 contributor: fullname: Yin – volume: 15 start-page: 1092 year: 2019 ident: ref_62 article-title: Circulating miR-21 and miR-155 as Potential Noninvasive Biomarkers in Iranian Azeri Patients with Breast Carcinoma publication-title: J. Cancer Res. Ther. doi: 10.4103/jcrt.JCRT_1227_16 contributor: fullname: Soleimanpour – ident: ref_124 doi: 10.1177/1010428318791887 – volume: 11 start-page: 210 year: 2020 ident: ref_61 article-title: Life, Death, and Autophagy in Cancer: NF-κB Turns up Everywhere publication-title: Cell Death Dis. doi: 10.1038/s41419-020-2399-y contributor: fullname: Verzella – volume: 147 start-page: 61 year: 2014 ident: ref_137 article-title: Changes in Serum Levels of miR-21, miR-210, and miR-373 in HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Translational Research Project within the Geparquinto Trial publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-014-3079-3 contributor: fullname: Gade – volume: 277 start-page: 33 year: 2017 ident: ref_44 article-title: miR-221/222 Promote Cancer Stem-like Cell Properties and Tumor Growth of Breast Cancer via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation publication-title: Chem.-Biol. Interact. doi: 10.1016/j.cbi.2017.08.014 contributor: fullname: Li – volume: 127 start-page: 90 year: 2021 ident: ref_72 article-title: Serum MiRNA-27a as Potential Diagnostic Nucleic Marker for Breast Cancer publication-title: Arch. Physiol. Biochem. doi: 10.1080/13813455.2019.1616765 contributor: fullname: Swellam – volume: 29 start-page: 4273 year: 2011 ident: ref_15 article-title: Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2010.31.2835 contributor: fullname: Cuzick – ident: ref_138 doi: 10.3390/ijms21165834 – volume: 9 start-page: 606 year: 2004 ident: ref_14 article-title: Prognostic and Predictive Factors in Early-Stage Breast Cancer publication-title: Oncologist doi: 10.1634/theoncologist.9-6-606 contributor: fullname: Cianfrocca – volume: 9 start-page: 12 year: 2010 ident: ref_79 article-title: miR-21: An Oncomir on Strike in Prostate Cancer publication-title: Mol. Cancer doi: 10.1186/1476-4598-9-12 contributor: fullname: Folini – volume: 17 start-page: 990 year: 2019 ident: ref_122 article-title: miR-1207-5p Regulates the Sensitivity of Triple-negative Breast Cancer Cells to Taxol Treatment via the Suppression of LZTS1 Expression publication-title: Oncol. Lett. contributor: fullname: Hou – ident: ref_133 doi: 10.3390/ncrna5040053 – volume: 24 start-page: e1044 year: 2019 ident: ref_103 article-title: Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer publication-title: Oncologist doi: 10.1634/theoncologist.2018-0697 contributor: fullname: Tan – volume: 19 start-page: 230 year: 2013 ident: ref_70 article-title: MicroRNA-182-5p Targets a Network of Genes Involved in DNA Repair publication-title: RNA doi: 10.1261/rna.034926.112 contributor: fullname: Krishnan – volume: 144 start-page: 646 year: 2011 ident: ref_116 article-title: Hallmarks of Cancer: The Next Generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 contributor: fullname: Hanahan – volume: 18 start-page: 350 year: 2008 ident: ref_81 article-title: MicroRNA-21 Targets Tumor Suppressor Genes in Invasion and Metastasis publication-title: Cell Res. doi: 10.1038/cr.2008.24 contributor: fullname: Zhu – volume: 8 start-page: 17981 year: 2018 ident: ref_86 article-title: Plasma miR-21, miR-155, miR-10b, and Let-7a as the Potential Biomarkers for the Monitoring of Breast Cancer Patients publication-title: Sci. Rep. doi: 10.1038/s41598-018-36321-3 contributor: fullname: Khalighfard – volume: 92 start-page: 55 year: 2017 ident: ref_64 article-title: A Novel Panel of Serum miR-21/miR-155/miR-365 as a Potential Diagnostic Biomarker for Breast Cancer publication-title: Ann. Surg. Treat. Res. doi: 10.4174/astr.2017.92.2.55 contributor: fullname: Han – volume: 11 start-page: 696269 year: 2021 ident: ref_41 article-title: MiR-526b-3p Attenuates Breast Cancer Stem Cell Properties and Chemoresistance by Targeting HIF-2α/Notch Signaling publication-title: Front. Oncol. doi: 10.3389/fonc.2021.696269 contributor: fullname: Liu – volume: 165 start-page: 417 year: 2015 ident: ref_87 article-title: Breast Tissue–Based microRNA Panel Highlights microRNA-23a and Selected Target Genes as Putative Biomarkers for Breast Cancer publication-title: Transl. Res. doi: 10.1016/j.trsl.2014.10.001 contributor: fullname: Eissa – volume: 7 start-page: 304 year: 2015 ident: ref_3 article-title: Optimal Management of Hormone Receptor Positive Metastatic Breast Cancer in 2016 publication-title: Ther. Adv. Med. Oncol. doi: 10.1177/1758834015608993 contributor: fullname: Reinert – volume: 32 start-page: 2858 year: 2014 ident: ref_37 article-title: MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway publication-title: Stem Cells doi: 10.1002/stem.1795 contributor: fullname: Zhang – volume: 2020 start-page: 9514831 year: 2020 ident: ref_136 article-title: Clinical Evaluation of the Diagnostic Role of MicroRNA-155 in Breast Cancer publication-title: Int. J. Genom. contributor: fullname: Aalami – volume: 8 start-page: 28939 year: 2017 ident: ref_27 article-title: Suppressive Role Exerted by microRNA-29b-1-5p in Triple Negative Breast Cancer through SPIN1 Regulation publication-title: Oncotarget doi: 10.18632/oncotarget.15960 contributor: fullname: Pentimalli – ident: ref_118 doi: 10.3390/molecules21030290 – volume: 10 start-page: 202 year: 2008 ident: ref_74 article-title: The microRNAs miR-373 and miR-520c Promote Tumour Invasion and Metastasis publication-title: Nat. Cell Biol. doi: 10.1038/ncb1681 contributor: fullname: Huang – volume: 109 start-page: 1404 year: 2018 ident: ref_117 article-title: MicroRNA-708-3p Mediates Metastasis and Chemoresistance through Inhibition of Epithelial-to-Mesenchymal Transition in Breast Cancer publication-title: Cancer Sci. doi: 10.1111/cas.13588 contributor: fullname: Lee – volume: 48 start-page: 471 year: 2016 ident: ref_46 article-title: PIK3R1 Targeting by miR-21 Suppresses Tumor Cell Migration and Invasion by Reducing PI3K/AKT Signaling and Reversing EMT, and Predicts Clinical Outcome of Breast Cancer publication-title: Int. J. Oncol. doi: 10.3892/ijo.2015.3287 contributor: fullname: Yan – volume: 18 start-page: 2256 year: 2017 ident: ref_21 article-title: miR-600 Acts as a Bimodal Switch That Regulates Breast Cancer Stem Cell Fate through WNT Signaling publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.02.016 contributor: fullname: Pinna – volume: 33 start-page: 29 year: 2023 ident: ref_94 article-title: Screening and Bioinformatics Analysis of MicroRNA Biomarkers in Triple-Negative Breast Cancer publication-title: Crit. Rev. Eukaryot. Gene Expr. doi: 10.1615/CritRevEukaryotGeneExpr.2023046030 contributor: fullname: Fan – volume: 213 start-page: 418 year: 2017 ident: ref_93 article-title: Predictors of 5-Year Local, Regional, and Distant Recurrent Events in a Population-Based Cohort of Breast Cancer Patients publication-title: Am. J. Surg. doi: 10.1016/j.amjsurg.2016.03.016 contributor: fullname: Fung – volume: 17 start-page: 1600375 year: 2017 ident: ref_119 article-title: Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles publication-title: Proteomics doi: 10.1002/pmic.201600375 contributor: fullname: Samuel – volume: 10 start-page: 593 year: 2008 ident: ref_131 article-title: The miR-200 Family and miR-205 Regulate Epithelial to Mesenchymal Transition by Targeting ZEB1 and SIP1 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1722 contributor: fullname: Gregory – volume: 8 start-page: e1092 year: 2020 ident: ref_83 article-title: Plasma-based microRNA Signatures in Early Diagnosis of Breast Cancer publication-title: Mol. Gen. Gen. Med. doi: 10.1002/mgg3.1092 contributor: fullname: Li – volume: 19 start-page: 20 year: 2021 ident: ref_105 article-title: Cancer-Derived Exosomal miR-7641 Promotes Breast Cancer Progression and Metastasis publication-title: Cell Commun. Signal doi: 10.1186/s12964-020-00700-z contributor: fullname: Shen |
SSID | ssj0023259 |
Score | 2.4520578 |
SecondaryResourceType | review_article |
Snippet | Breast cancer (BC) is the most diagnosed cancer in women and the second most common cancer globally. Significant advances in BC research have led to improved... |
SourceID | doaj proquest gale crossref |
SourceType | Open Website Aggregation Database |
StartPage | 16010 |
SubjectTerms | Apoptosis B cells Biomarkers Breast cancer breast cancer stem cells Cancer Cancer therapies Cell growth Chemotherapy Development and progression Diagnosis diagnostic Enzymes Gene expression Genes Genetic engineering Genotype & phenotype Homeostasis Kinases Metastasis MicroRNA MicroRNAs miRNAs Oncology, Experimental Patients Prognosis prognostic Proteins Reproducibility signature Stem cells Transplantation |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOglJG1DNi9UCO3JxJZkyTputg1LD0tIs5Cb0MuwJbHD2jnk32fG8obsIfRS8MXWCKQZSfONPA9CzpUEDM3x6s0ynYnobOYkrGWF-t0FCYh2cJBdyPlS_L4r796U-kKfsJQeODHuwhZWSlF5zoISZdQuOM28VDaXzroi5fnM9caYGk0tzoYyaQVon0yWWqbsmhwM_IvV34cO_4MWaIpsaaMhaf97R_Ogb672yO4IFOk0DXCffIjNZ_IxlY58_kK6ZYOFgzCYnAKGo9dtj34_0KOt6cPqZjHtKIaO0NmfWUctPA3FCyisSUTHZKD39LZt7ynAVnqJvuk9neEaWNOfyf9uhb0CvV636e0rWV79up3Ns7GAQuaFyvtMaG55sKWMRVBShdqKOgpXWThtvS5BN8e64iDDUte5ZCF3gA4V80rXkTuv-AHZadomHhLqYlGp2oPBDPo8SG-liKD1WOUl95yHCfm-YaR5THkyDNgXyHGzxfEJuUQ2vxJheuvhAwjdjEI3_xL6hPxAIRnchP3aejvGEsBYMZ2VmcIsAMdyBpQnW5Swefx280bMZty8nWFVVSHM0npCvr02Y090SGti-zTQALRmML-j_zGhY_IJ69inIMcTstOvn-IpoJ3enQ0L-wXllPot priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4imWFmQkBKeoG9ux4xPaLiwVh6qCrtSb5VfQojYuSXrov2cm8S7aA0i5JB5HiT32fDOeByHvlQQMzdH0ZpkuRHS2cBJ4WaF8d0ECoh0dZM_k6Vp8u6wus8Gtz26V2z1x3KhD8mgjP2agqqHs0_rTze8Cq0bh6WouoXGfPCiZUqh81auvO4WLs7FYWgkyqJCVllOOTQ5q_vHm13WPp6ElKiR7MmlM3f-vDXqUOqsn5HGGi3Qxze9Tci-2z8jDqYDk3XPSr1ssH4Qh5RSQHD1PA3r_QI_U0OvN97NFTzGAhC5_LHtq4WopmqGwMhHNKUGv6EVKVxTAKz1BD_WBLpETOvp58sLbYK9Az7s03b0g69WXi-VpkcsoFF6o-VAIzS0PtpKxDEqq0FjRROFqC3uu1xVI6NjUHGay0s1csjB3gBEV80o3kTuv-Ety0KY2viLUxbJWjQe1GaR6kN5KEUH2sdpL7jkPM_JhO5DmZsqWYUDLwBE3eyM-Iyc4zDsiTHI9PkjdT5PXjLGllVLUnrOgRBW1C04zL5WdS2ddyWfkI06SwaU4dNbbHFEA34pJrcwC_gLQLGdAebRHCUvI7zdvp9nkJdybvww3I-92zdgT3dLamG5HGgDYDP7v9f9fcUgeYZ36KYjxiBwM3W18A2hmcG9Hlv0D9FzxbA priority: 102 providerName: ProQuest |
Title | Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis |
URI | https://www.proquest.com/docview/2888155499 https://search.proquest.com/docview/2889992339 https://doaj.org/article/a1a6648c32d745e9bdb92c67a06bab13 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96h-CL-ImrZ4kg-lTdJmnSPojsrrcePizLeQv7VvJVWdlr79oeeP-9M2l3ZfEDSqFNQpvJJPObZD4IeaMkYGiOW2-a5bHwRsdGAi8rlO_GSUC0wUB2Ic9W4us6Xf8OKTQQsP2raof5pFbN9v3P69tPMOE_osYJKvuHzY_LFk82ExmcrY6ZACUdrfjE_kABcEPIm4Y7HjGu0H24zT-bH4inEMX_X2t1EEDzh-TBgBzppB_qR-SOrx6Te30uydsnpF1VmEkIvcspgDq6rDs0BIIWdUkvN-eLSUvRl4TOvs1aquGqKO5IYZIiOkQH3dKLut5SwLF0isbqHZ0hUzT0c2-Qt8FWji6bun96Slbz04vZWTxkVIitUOMuFjnX3OlU-sQpqVypRemFyTQsvzZPQVj7MuMwqGlejiVzYwNwUTGr8tJzYxV_Ro6quvLPCTU-yVRpQYMGAe-k1VJ4EIMss5Jbzt2IvN0RsrjqA2cUoHAgxYsDio_IFMm8r4TxrsOLuvleDNOn0ImWUmSWM6dE6nPjTM6sVHosjTYJH5F3OEgF8knXaKsH5wL4V4xvVUygFwBsOYOaJwc1YTbZw-LdMBc7ZixYlmWIu_J8RF7vi7ElWqhVvr4JdQBrM-jfi_9_4SW5jynre3_GE3LUNTf-FQCbzkTkrloruGfzLxE5np4uludR2CSIUOCkUWDpX-JT-Ps |
link.rule.ids | 315,783,787,867,2109,2228,12068,12777,21400,24330,27936,27937,31731,31732,33385,33386,33756,33757,43322,43612,43817,74079,74369,74636 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgCMEL4qoVxjASgqdoje3Y8RPqykqBUU3QSnuzfMvUaUtGkj3w7zknSYv6AFJeEttR4tv3neNzIeSdksChOareLNOJiM4mTsJcVojvLkhgtJ2B7ELOV-LreXY-KNyawaxysyd2G3WoPOrIjxiIaoh9Wn-8-ZVg1ig8XR1SaNwl9wQHrEZP8dnnrcDFWZcsLQUMSmSmZR9jk4OYf7S-vG7wNDRFgWQHk7rQ_f_aoDvUmT0mjwa6SCf9-D4hd2L5lNzvE0j-fkaaVYnpg9ClnAKTo2dVi9Y_0KIq6PX6x2LSUHQgodOf04ZauEqKaijMTESHkKBXdFlVVxTIKz1GC_WWTnEm1PRTb4W3xlaBntVVf_ecrGYny-k8GdIoJF6ocZsIzS0PNpMxDUqqUFhRROFyC3uu1xkgdCxyDiOZ6WIsWRg74IiKeaWLyJ1X_AXZK6sy7hPqYpqrwoPYDKgepLdSRMA-lnvJPedhRN5vOtLc9NEyDEgZ2ONmp8dH5Bi7eVsJg1x3D6r6wgxrxtjUSilyz1lQIovaBaeZl8qOpbMu5SPyAQfJ4FJsa-vt4FEA34pBrcwE_gLYLGdQ82CnJiwhv1u8GWYzLOHG_J1wI_J2W4wt0SytjNVtVwcINoP_e_n_V7whD-bL76fm9Mvi2yvyEHPW9w6NB2SvrW_ja2A2rTvspu8fUiX0Tg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgCMQLGjfRMcBICJ6iNnZix0-o6yjjoqqCVdqb5VtQ0ZZsSfawf79zErdTH0DKS2I7Suxjf9-xz4WQD1IAh-a49WaYSrJgTWIFyLJEfLdeAKPtDWQX4mSVfT_Lz6L9UxvNKjdrYr9Q-9rhHvmYgaqG2KfUuIxmEcvj-efLqwQzSOFJa0yncZ88AFQUKOHF_OtW-eKsT5yWAh4lIldiiLfJQeUfr_9etHgymqJysoNPfRj_fy3WPQLN98mTSB3pdBjrp-ReqJ6Rh0MyyZvnpF1VmEoI3cspsDq6rDu0BIIWdUkv1r8W05aiMwmd_Z611MBVUdySwixFNIYHPaendX1OgcjSI7RW7-gMpaKhx4NF3hpbebps6uHuBVnNv5zOTpKYUiFxmZx0Saa44d7kIqReCulLk5Uhs4WB9depHNA6lAWHUc1VORHMTyzwRcmcVGXg1kn-kuxVdRVeEWpDWsjSgQoNCO-FMyILgIOscII7zv2IfNx0pL4cImdo0Diwx_VOj4_IEXbzthIGvO4f1M0fHeePNqkRIiscZ15meVDWW8WckGYirLEpH5FPOEgap2XXGGeidwF8Kwa40lP4C2C2nEHNw52aMJ3cbvFmmHWczq2-E74Reb8txpZoolaF-rqvA2Sbwf8d_P8V78gjkFz989vix2vyGNPXD76Nh2Sva67DGyA5nX3bS-8t7Nj4jA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unraveling+the+Potential+of+miRNAs+from+CSCs+as+an+Emerging+Clinical+Tool+for+Breast+Cancer+Diagnosis+and+Prognosis&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Nogueras+P%C3%A9rez%2C+Raquel&rft.au=Heredia-Nicol%C3%A1s%2C+Noelia&rft.au=de+Lara-Pe%C3%B1a%2C+Laura&rft.au=L%C3%B3pez+de+Andr%C3%A9s%2C+Julia&rft.date=2023-11-01&rft.pub=MDPI+AG&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=24&rft.issue=21&rft_id=info:doi/10.3390%2Fijms242116010&rft.externalDocID=A772533323 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |